2015
DOI: 10.1016/j.yjmcc.2015.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Uniaxial cyclic stretch stimulates TRPV4 to induce realignment of human embryonic stem cell-derived cardiomyocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
21
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 28 publications
(23 citation statements)
references
References 30 publications
1
21
1
Order By: Relevance
“…The cytosolic Ca 2+ was measured as described elsewhere (Qi et al, 2015). Briefly, NRCMs were loaded with 5 μmol/L Fluo-4/AM (Invitrogen, Waltham, MA, USA) for 40 min in normal Tyrode’s solution that contained in mmol/L, 140 NaCl, 5.4 KCl, 1 MgCl 2 , 2 CaCl 2 , 5.5 glucose and 5 HEPES at pH 7.4.…”
Section: Methodsmentioning
confidence: 99%
“…The cytosolic Ca 2+ was measured as described elsewhere (Qi et al, 2015). Briefly, NRCMs were loaded with 5 μmol/L Fluo-4/AM (Invitrogen, Waltham, MA, USA) for 40 min in normal Tyrode’s solution that contained in mmol/L, 140 NaCl, 5.4 KCl, 1 MgCl 2 , 2 CaCl 2 , 5.5 glucose and 5 HEPES at pH 7.4.…”
Section: Methodsmentioning
confidence: 99%
“…Various experiments have been developed to determine the physiological function of MSCs, which have exposed cells to various mechanical loads in situ. In such electrophysiological experiments, cells have been exposed to cell stretch, 42 45 shear flow, 46 48 membrane indentation, 49 51 osmotic challenges, 52 , 53 hydrostatic pressure 54 56 and other loading conditions. In line with these experiments, mechanical unloading, as experienced in microgravity, represents an interesting condition, since exposure to microgravity leads to a series of physiological adaption processes (reviewed in refs.…”
Section: Mechanosensitivity Of Ion Channelsmentioning
confidence: 99%
“…Neuronal TRPV4 channels may therefore be an important therapeutic target for cognitive, motor and ageing-related disorders. TRPV4 inhibitors have been described and were recently described as orally available compounds (Jia et al 2004;Krause et al 2005;Phan et al 2009;Vincent et al 2009;Morty & Kuebler, 2014;Feetham et al 2015;Qi et al 2015) and also as 'dual inhibitors' of TRPV4 and TRPA1 (Kanju et al 2016), which might be an attractive possibility given the postulated function of astrocytic TRPA1 (Lee et al 2012;Shigetomi et al 2012Shigetomi et al , 2013Wei et al 2016). Such inhibitors, if they are intended for oral use, will have to pass through the blood-brain barrier (although, for example, the blood-brain barrier is more penetrable in certain CNS disorders, such as multiple sclerosis).…”
Section: Role Of Trpv4 In Cns Neuronsmentioning
confidence: 99%
“…; Qi et al . ) and also as ‘dual inhibitors’ of TRPV4 and TRPA1 (Kanju et al . ), which might be an attractive possibility given the postulated function of astrocytic TRPA1 (Lee et al .…”
Section: Introductionmentioning
confidence: 99%